These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 7678717)

  • 1. Glomerular C3c localization indicates ongoing immune deposit formation and complement activation in experimental glomerulonephritis.
    Schulze M; Pruchno CJ; Burns M; Baker PJ; Johnson RJ; Couser WG
    Am J Pathol; 1993 Jan; 142(1):179-87. PubMed ID: 7678717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g.
    Davis AE; Harrison RA; Lachmann PJ
    J Immunol; 1984 Apr; 132(4):1960-6. PubMed ID: 6607952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased urinary excretion of C5b-9 distinguishes passive Heymann nephritis in the rat.
    Schulze M; Baker PJ; Perkinson DT; Johnson RJ; Ochi RF; Stahl RA; Couser WG
    Kidney Int; 1989 Jan; 35(1):60-8. PubMed ID: 2651753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary excretion of C5b-9 reflects disease activity in passive Heymann nephritis.
    Pruchno CJ; Burns MW; Schulze M; Johnson RJ; Baker PJ; Couser WG
    Kidney Int; 1989 Jul; 36(1):65-71. PubMed ID: 2681928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunopathological correlation between mesangial C3d-deposition and C3d-fixing circulating immune complexes in lupus nephritis.
    Muso E; Sekita K; Doi T; Kuwahara T; Yoshida H; Tamura T; Kawai C; Hamashima Y
    Clin Immunol Immunopathol; 1984 Sep; 32(3):351-8. PubMed ID: 6380844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of glomerular deposition of C3c and C3d in IgA nephropathy.
    Nakagawa H; Suzuki S; Haneda M; Gejyo F; Kikkawa R
    Am J Nephrol; 2000; 20(2):122-8. PubMed ID: 10773612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of a C3c specific monoclonal antibody and assessment of C3c as a putative inflammatory marker derived from complement factor C3.
    Palarasah Y; Skjodt K; Brandt J; Teisner B; Koch C; Vitved L; Skjoedt MO
    J Immunol Methods; 2010 Oct; 362(1-2):142-50. PubMed ID: 20869965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement system promotes transfer of immune complex across glomerular filtration barrier.
    Fujigaki Y; Batsford SR; Bitter-Suermann D; Vogt A
    Lab Invest; 1995 Jan; 72(1):25-33. PubMed ID: 7837787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental membranous glomerulonephritis in rats. Quantitative studies of glomerular immune deposit formation in isolated glomeruli and whole animals.
    Salant DJ; Darby C; Couser WG
    J Clin Invest; 1980 Jul; 66(1):71-81. PubMed ID: 7400310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis.
    Susani M; Schulze M; Exner M; Kerjaschki D
    Am J Pathol; 1994 Apr; 144(4):807-19. PubMed ID: 8160779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glomerular complement regulation is overwhelmed in passive Heymann nephritis.
    Cunningham PN; Hack BK; Ren G; Minto AW; Morgan BP; Quigg RJ
    Kidney Int; 2001 Sep; 60(3):900-9. PubMed ID: 11532085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of the role of complement depletion in experimental membranous nephropathy in the rat.
    Gabbai FB; Mundy CA; Wilson CB; Blantz RC
    Lab Invest; 1988 May; 58(5):539-48. PubMed ID: 3367636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement-coated antibody-transfer (CCAT); serum IgA1 antibodies intercept and transport C4 and C3 fragments and preserve IgG1 deployment (PGD).
    Boackle RJ; Nguyen QL; Leite RS; Yang X; Vesely J
    Mol Immunol; 2006 Feb; 43(3):236-45. PubMed ID: 16199260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glomerular deposition and urinary excretion of complement factor H in idiopathic membranous nephropathy.
    Endo M; Fuke Y; Tamano M; Hidaka M; Ohsawa I; Fujita T; Ohi H
    Nephron Clin Pract; 2004; 97(4):c147-53. PubMed ID: 15331938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glomerular handling of immune complex in the acute phase of active in situ immune complex glomerulonephritis employing cationized ferritin in rats. Ultrastructural localization of immune complex, complements and inflammatory cells.
    Fujigaki Y; Nagase M; Kojima K; Yamamoto T; Hishida A
    Virchows Arch; 1997 Jul; 431(1):53-61. PubMed ID: 9247633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the terminal complement pathway in experimental membranous nephropathy in the rabbit.
    Groggel GC; Adler S; Rennke HG; Couser WG; Salant DJ
    J Clin Invest; 1983 Dec; 72(6):1948-57. PubMed ID: 6227634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glomerular CR1 express in situ cofactor activity for degradation of C3b.
    Vedeler CA; Matre R; Iversen BM
    Int Arch Allergy Appl Immunol; 1990; 92(1):60-3. PubMed ID: 2147176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration of C3d deposits in membranous nephropathy.
    Doi T; Kanatsu K; Nagai H; Suehiro F; Kuwahara T; Hamashima Y
    Nephron; 1984; 37(4):232-5. PubMed ID: 6379483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental studies on membranous nephropathy. (II) Role of complement system in proteinuria of passive Heymann nephritis.
    Nishi T; Nosaka K; Kawasaki H
    Nihon Jinzo Gakkai Shi; 1984 Mar; 26(3):301-7. PubMed ID: 6748340
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunohistochemical study of the C5b-9 complex of complement in human kidneys.
    Hinglais N; Kazatchkine MD; Bhakdi S; Appay MD; Mandet C; Grossetete J; Bariety J
    Kidney Int; 1986 Sep; 30(3):399-410. PubMed ID: 3537447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.